ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Traws Pharma Inc

Traws Pharma Inc (TRAW)

8.06
-0.01
(-0.12%)
終了 1月11日 6:00AM
12.28
4.22
(52.36%)
取引時間後: 9:59AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
12.28
買値
12.09
売値
12.71
出来高
344,419
8.0501 日の範囲 8.32
4.06 52 週間の範囲 24.75
時価総額
前日終値
8.07
始値
8.07
最終取引時間
財務取引量
US$ 2,808,014
VWAP
8.1529
平均取引量 (3 か月)
568,403
発行済株式数
3,025,554
配当利回り
-
PER
-1.29
1 株当たり利益 (EPS)
-6.26
歳入
226k
純利益
-18.95M

Traws Pharma Inc について

Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, pr... Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor ON 123300 is currently in a dose-escalation and expansion Phase 1 trial in China, and an IND has been filed in the U.S. Its product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Traws Pharma Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker TRAW. The last closing price for Traws Pharma was US$8.07. Over the last year, Traws Pharma shares have traded in a share price range of US$ 4.06 to US$ 24.75.

Traws Pharma currently has 3,025,554 shares in issue. The market capitalisation of Traws Pharma is US$24.42 million. Traws Pharma has a price to earnings ratio (PE ratio) of -1.29.

TRAW 最新ニュース

Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program

Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program PR Newswire SAN DIEGO, Jan. 10, 2025 SAN DIEGO, Jan. 10, 2025 /PRNewswire/ -- Expert Systems, a hybrid AI...

Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval

Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval PR...

Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu

Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu PR Newswire NEWTOWN, Pa., Dec. 23, 2024 Investigational agent in development for treatment or prevention of H5N1...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
13.6642.45939675178.6212.768.061487318.78988145CS
47.39151.1247443764.8919.444.619188624012.24306674CS
127.6162.3931623934.6819.444.0656840312.16806166CS
263.60541.55619596548.67519.444.0629834011.6269141CS
52-12.47-50.383838383824.7524.754.0623491612.34809927CS
156-12.47-50.383838383824.7524.754.0623491612.34809927CS
260-12.47-50.383838383824.7524.754.0623491612.34809927CS

TRAW - Frequently Asked Questions (FAQ)

What is the current Traws Pharma share price?
The current share price of Traws Pharma is US$ 12.28
How many Traws Pharma shares are in issue?
Traws Pharma has 3,025,554 shares in issue
What is the market cap of Traws Pharma?
The market capitalisation of Traws Pharma is USD 24.42M
What is the 1 year trading range for Traws Pharma share price?
Traws Pharma has traded in the range of US$ 4.06 to US$ 24.75 during the past year
What is the PE ratio of Traws Pharma?
The price to earnings ratio of Traws Pharma is -1.29
What is the cash to sales ratio of Traws Pharma?
The cash to sales ratio of Traws Pharma is 107.9
What is the reporting currency for Traws Pharma?
Traws Pharma reports financial results in USD
What is the latest annual turnover for Traws Pharma?
The latest annual turnover of Traws Pharma is USD 226k
What is the latest annual profit for Traws Pharma?
The latest annual profit of Traws Pharma is USD -18.95M
What is the registered address of Traws Pharma?
The registered address for Traws Pharma is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Traws Pharma website address?
The website address for Traws Pharma is www.onconova.com
Which industry sector does Traws Pharma operate in?
Traws Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.7M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.69M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.56M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.16B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.45M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.69M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.83M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.31M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.16B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
203.27M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
175.21M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
174.99M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.56M

TRAW Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock